Boots recalls cough medicines

Boots has recalled some of its cough and cold medicines over fears that plastic might have got into the liquid.

Boots: 'Health and safety of customers is always our highest priority'

Boots has recalled some of its cough and cold medicines over fears that plastic might have got into the liquid.

The health and safety of our customers and patients is always our highest priority so as a precaution we are recalling some Boots Pharmaceuticals medicine lines.

Whilst we're not currently aware of any customer incidences, we have taken the decision to ask customers to return these products to our stores for a refund.

We're sorry for any inconvenience this may cause our customers and would like to offer our reassurances that these actions are taken as a precaution, while we fully investigate the situation.

– Boots

Read more here.

National

Shoppers asked to return some cold medicines to Boots

Shoppers are being asked to return the medicine to Boots as a precautionary measure, where they will get a refund.

Anyone with questions can telephone the Boots Customer Care Line on 0800 915 0004, or contact the healthcare team at their local Boots store.

The medicines are:

  • Boots Pharmaceuticals Paracetamol 6 years Plus (250mg/5ml oral solution 200ml)
  • Boots Pharmaceuticals Ibuprofen 3 Months Plus (100mg/5ml oral suspension, strawberry flavour)
  • Boots Pharmaceuticals Chesty Cough Relief (100mg/5ml oral solution)
  • Boots Pharmaceuticals Dry Cough Relief oral solution
  • Boots Pharmaceuticals Mucus Cough Relief (100mg/5ml oral solution)

Read: Boots recalls cough and cold medicines

Advertisement

Boots recalls cough and cold medicines

Boots has recalled some of its cough and cold medicines over fears that plastic might have got into the liquid.

The pharmacy company, based in Nottingham, said it identified a possible fault in the manufacturing process of the tamper seal which might result in small pieces of plastic getting into the solutions.

A Boots store Credit: Anna Gowthorpe/PA

The Medicines and Healthcare products Regulatory Agency (MHRA) published the company-led recall for medicines purchased since September.

There is "currently no evidence" of any problems among people who have taken the medicines, MHRA said.